Spora Health, a San Francisco, CA-based telemedicine startup offering primary care services for people of color, raised $3m in Seed Plus funding.
The round was led by M13, Refactor Capital, and MaC Venture Capital with participation from existing investors Human Ventures, Headwater Ventures, Techstars, and Alicia Jackson, CEO of Ever Now.
The company intends to use the funds to accelerate investment in hiring, product development and marketing initiatives to further expand its footprint in the U.S.
Founded in 2019 by Dan Miller, Spora Health is a primary care network that offers a virtual first solution designed specifically for people of color. The company offers patients membership-based telemedicine services for common health ailments, including allergies, cold and flu, common infections, digestive system, musculoskeletal, reproductive system, and skin conditions such as wounds, burns, rashes, acne, eczema. Its machine learning technology can predict risk profiles for patients and looks for chronic conditions like pre-diabetes, hypertension, emphysema and more. It is available in Pennsylvania, Virginia, Florida and Tennessee.
In addition, the company appointed Louis Capponi, MD, to the newly created position of chief medical officer, where he will oversee clinical development and regulatory initiatives. Dr. Capponi, who brings more than 25 years of experience in clinical leadership and business operations, previously held roles as Chief Medical Information Officer at Cleveland Clinic and Vice President and Chief Medical Informatics Officer at SCL Health in Denver, CO.